Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders, has introduced its new Leksell Gamma Knife Icon. The benefits of precision cranial radiosurgery are now available for more patients with a wider variety of brain tumor types and sizes. This latest generation stereotactic radiosurgery system for the brain, integrates advanced motion management, dose delivery and imaging technologies, significantly increasing the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon at the 3rd ESTRO Forum in Barcelona.
Icon provides increased flexibility by allowing physicians to choose either frame-based or frameless methods to immobilise the patient’s head, in addition to the option to perform the treatment in a single session or multiple sessions (fractions or hypofractionation). The system even enables clinicians to choose the degree of precision needed for each patient’s case – ranging from traditional radiosurgery accuracy to ultra-precise microradiosurgery.
Elekta developed Icon to treat almost any intracranial target. It offers new functionality familiar to radiation oncologists, such as cone beam CT, which should help increase the adoption of radiosurgery. Leksell Gamma Knife Icon is not for sale or distribution in the US and is not CE marked.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care
Subscribe to PharmaTutor News Alerts by Email >>
